Comparison between Mehai Technology IPO and Trident Texofab IPO.
Mehai Technology IPO is a SME Fixed Price IPO proposed to list at BSE SME while Trident Texofab IPO is a SME Fixed Price proposed to list at BSE SME.
| Mehai Technology IPO | Trident Texofab IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | SPA Capital Advisors Ltd. | Oneview Corporate Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Guiness Securities Ltd. | Guiness Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Mehai Technology IPO is up to ₹5.69 Cr whereas the issue size of the Trident Texofab IPO is up to ₹3.34 Cr. The final issue price of Mehai Technology IPO is ₹40.00 per share and of Trident Texofab IPO is ₹30.00 per share.
| Mehai Technology IPO | Trident Texofab IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹40.00 per share | ₹30.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 4000 shares |
| Fresh Issue Size | 14,22,000 shares | 11,12,000 shares |
| Fresh Issue Size (Amount) | up to ₹5.69 Cr | up to ₹3.34 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 14,22,000 shares | 11,12,000 shares |
| Issue Size Total (Amount) | up to ₹5.69 Cr | up to ₹3.34 Cr |
Mehai Technology IPO opens on Sep 25, 2017, while Trident Texofab IPO opens on Sep 21, 2017. The closing date of Mehai Technology IPO and Trident Texofab IPO is Sep 28, 2017, and Sep 26, 2017, respectively.
| Mehai Technology IPO | Trident Texofab IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 25, 2017 | Sep 21, 2017 |
| Issue Close | Sep 28, 2017 | Sep 26, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Oct 09, 2017 | Oct 05, 2017 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Mehai Technology IPO P/E ratio is , as compared to Trident Texofab IPO P/E ratio of .
| Mehai Technology IPO | Trident Texofab IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | ||||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹21.42 Cr. | ₹11.99 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Mehai Technology IPO Retail Individual Investors (RII) are offered 7,11,000 shares while in Trident Texofab IPO retail investors are offered 7,11,000 shares. Qualified Institutional Buyers (QIB) are offered in Mehai Technology IPO and in Trident Texofab IPO.
| Mehai Technology IPO | Trident Texofab IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 78,000 shares | 64,000 shares |
| QIB | ||
| NII | 7,11,000 shares | 5,56,000 shares |
| RII | 7,11,000 shares | 5,56,000 shares |
| Employee | ||
| Others | ||
| Total | 14,22,000 shares | 11,12,000 shares |
Mehai Technology IPO subscribed 1.73x in total, whereas Trident Texofab IPO subscribed 8.09x.
| Mehai Technology IPO | Trident Texofab IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 0.86x | 3.45x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.60x | 12.73x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.73x | 8.09x |
